Latest News - Cencora
Top Corporates Hub
Cencora
Cencora Appoints Eva Boratto as Executive Vice President and Chief Financial Officer
27.05.2026 10:55
CONSHOHOCKEN, Pa., May 27, 2026--Cencora, Inc. (NYSE: COR) today announced Eva C. Boratto has been appointed Executive Vice President and Chief Financial Officer of the Company, effective June 29, 2026. Ms. Boratto succeeds James F. Cleary, who will be retiring from his role as Executive Vice President and Chief Financial Officer as previously announced. Mr. Cleary will serve in an advisory capacity through the end of 2026 to help ensure a smooth transition.
Cencora (COR) Emerges as a Healthcare Leader with Robust Fundamentals and Strategic Re-Rating
18.05.2026 12:36
Latitude Investment Management, an investment management firm, released its fourth-quarter 2025 investor letter. A copy of the letter can be downloaded here. The letter emphasizes a long-term, fundamentals-driven investment philosophy, arguing that while stock prices can be volatile in the short run, they ultimately follow underlying earnings growth—illustrated through the “dog and owner” analogy. The […]
Wells Fargo Maintains Overweight Rating on Cencora (COR)
15.05.2026 13:25
Cencora, Inc. (NYSE:COR) is one of the 10 Best Depressed Stocks to Buy in 2026. On May 11, 2026, Wells Fargo analyst Stephen Baxter lowered the firm’s price target on Cencora, Inc. (NYSE:COR) to $331 from $429 while maintaining an Overweight rating on the shares. The firm said the magnitude of the slowdown in U.S. […]
Cencora, Inc. (COR) Presents at BofA Securities 2026 China Conference Transcript
13.05.2026 13:20
Cencora, Inc. (COR) BofA Securities 2026 China Conference May 13, 2026 11:00 AM EDTCompany ParticipantsRobert Mauch - President, CEO & DirectorJames...
Cencora, Inc. (COR) Presents at Bank of America Global Healthcare Conference 2026 Transcript
13.05.2026 13:10
Cencora, Inc. (COR) Bank of America Global Healthcare Conference 2026 May 13, 2026 11:00 AM EDTCompany ParticipantsRobert Mauch - President, CEO &...
Transcript : Cencora, Inc. Presents at BofA Securities 2026 China Conference, May-13-2026 08
13.05.2026 12:05
Presenter SpeechAllen Lutz All right. Good morning. Welcome to day 2 of the BofA Global Healthcare Conference. My name is Allen Lutz, I run health care tech and distribution here at Bank of
Transcript : Cencora, Inc. Presents at Bank of America Global Healthcare Conference 2026, May-13-2026 08
13.05.2026 12:05
Presenter SpeechAllen Lutz All right. Good morning. Welcome to day 2 of the BofA Global Healthcare Conference. My name is Allen Lutz, I run health care tech and distribution here at Bank of
US Stock Market Today S&P 500 Futures Inch Higher As Inflation Worries Ease
07.05.2026 10:08
The Morning Bull - US Market Morning Update Thursday, May, 7 2026 US stock futures are slightly higher this morning, with E-mini S&P 500 contracts up about 0.1%, as investors balance cooler bond markets, cheaper oil, and fresh US jobs data. The US 10 year Treasury yield is holding near 4.35%, which means borrowing costs for mortgages and companies remain relatively elevated but are not climbing further for now. Hopes of a US Iran peace deal are pulling oil prices lower and easing some...
Cencora : Q2 2026 Cencora Earnings Presentation
06.05.2026 07:02
Cencora, Inc. Second Quarter Fiscal 2026 Earnings Call May 6, 2026 Driving Growth: Cencora's Enterprise...
Cencora: Fiscal Q2 Earnings Snapshot
06.05.2026 06:49
CONSHOHOCKEN, Pa. — CONSHOHOCKEN, Pa. — Cencora, Inc. on Wednesday reported fiscal second-quarter net income of $1.64 billion. The Conshohocken, Pennsylvania-based company said it had profit...
Cencora Reports Fiscal 2026 Second Quarter Results
06.05.2026 06:31
Revenue of $78.4 billion for the Second Quarter, a 3.8 percent Increase Year-Over-YearSecond Quarter GAAP Diluted EPS of $8.40 and Adjusted Diluted EPS of $4.75Adjusted Diluted EPS Guidance...
Cencora Reports Fiscal 2026 Second Quarter Results
06.05.2026 06:31
Revenue of $78.4 billion for the Second Quarter, a 3.8 percent Increase Year-Over-YearSecond Quarter GAAP Diluted EPS of $8.40 and Adjusted Diluted EPS of $4.75Adjusted Diluted EPS Guidance...
Cencora to Report Q2 Earnings: What's in Store for the Stock?
05.05.2026 14:32
COR heads into Q2 earnings with expected steady specialty-driven growth, but customer losses and pricing pressures could temper results.
Cencora (COR) Reports Next Week: Wall Street Expects Earnings Growth
29.04.2026 14:00
Cencora (COR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
William Blair Initiates Coverage of Cencora (COR) with Market Perform Recommendation
29.04.2026 00:05
Cencora, Inc. (COR) Expands Into Retina Services Business in $1.1B Deal
24.04.2026 16:28
Cencora, Inc. (NYSE:COR) is one of the stocks positioned for breakout growth. On March 24, UBS reiterated a Buy rating on Cencora, Inc. (NYSE:COR) with a $410 price target. The bullish stance is in response to the company’s announcement of the acquisition of EyeSouth’s partner’s retina business for $1.1 billion. The acquisition marks an important […]
Cencora : Pharmaceutical supply chain experts discuss the transition to the FDA’s new 12-digit NDC format with Drug Topics and Pharmaceutical Commerce
24.04.2026 12:18
Matt Sample, SVP, manufacturer and replenishment operations at Cencora, and Neal Cooper, VP, regulatory affairs and quality systems at American Health Packaging, recently joined Drug Topics' Over the...
RIS Rx Welcomes Industry Pioneer Tom Doyle as Senior Advisor
24.04.2026 04:51
IRVINE, Calif. - RIS Rx, the healthcare technology company delivering real-time GTN Revenue Protection for the world's leading pharmaceutical manufacturers, today announced that Tom Doyle has joined...
Cencora Retina Deal Deepens Specialty Eye Care And Earnings Story
20.04.2026 04:18
Cencora (NYSE:COR) has agreed to acquire the retina business of EyeSouth Partners. The deal expands Cencora's specialty eye care operations and broadens its clinical network. The transaction focuses on retina services, a key area within ophthalmology care. Cencora operates as a pharmaceutical solutions organization with a focus on specialty distribution and services, and the move into EyeSouth Partners' retina business fits within that profile. Specialty eye care sits at the intersection of...
Camino Corporation Commences Drilling at Costa de Cobre District-Scale IOCG Copper Discovery in Peru
16.04.2026 10:00
VANCOUVER, BC / ACCESS Newswire / April 16, 2026 /Camino Minerals Corporation (TSXV:COR)(OTC PINK:CAMZF) ("Camino" or the "Company") is pleased to announce the commencement of a drilling campaign at its Costa de Cobre district-scale IOCG copper discovery ...